The Valley Desk

NCT06743126 · Interventional trial

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

Overall registry status Recruiting

Phase 3

Conditions Melanoma, Cutaneous Malignant, Mucosal Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov